AMLX Insider Trading

Insider Ownership Percentage: 12.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $20,559,000.00

Amylyx Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Amylyx Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amylyx Pharmaceuticals Share Price & Price History

Current Price: $28.03
Price Change: Price Increase of +0.16 (0.57%)
As of 09/26/2022 03:45 PM ET

This chart shows the closing price history over time for AMLX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Amylyx Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/8/2022Global Investors Lp VikingMajor ShareholderSell700,000$29.37$20,559,000.002,075,470View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Amylyx Pharmaceuticals (NASDAQ:AMLX)

44.65% of Amylyx Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Amylyx Pharmaceuticals logo
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Read More on Amylyx Pharmaceuticals

Today's Range

Now: $28.03
Low: $26.76
High: $28.89

50 Day Range

MA: $25.25
Low: $17.15
High: $30.92

52 Week Range

Now: $28.03
Low: $6.51
High: $33.41

Volume

23,990 shs

Average Volume

972,992 shs

Market Capitalization

$1.64 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals' top insider shareholders include:
  1. Global Investors Lp Viking (Major Shareholder)
Learn More about top insider investors at Amylyx Pharmaceuticals.